Cell & Gene Therapies: Rethinking Development & Value Creation

A Holistic Approach to Trial Design: Regulatory Pathway, Value Creation and Investment Proposition

  • Dr. Olga Kubassova

    IAG's CEO - Webinar Host

  • Dr. Sven Kili

    IAG's Cell and Gene Therapy Senior Leader - Webinar Presenter

  • , ,

    • We use cookies to improve our service, track analytics, remember preferences, etc. By using our site, you consent to these cookies. Click the "Info" button to read our privacy and cookie policies.

    INFO